热烈祝贺恩大细胞基因工程有限公司又荣获一项发明专利证书——一种含有NK细胞的药物组合物及其治疗癌症的用途。（Congratulations to Enda Cell Genetic Engineering Co., Ltd. for another invention patent certificate-a pharmaceutical composition containing NK cells and its use in treating cancer.）
本发明提供了一种含有NK细胞的药物组合物及其治疗癌症的用途，其中组合物包含发明人优化得到的NK细胞以及新制备的靶向CD38的抗体。所述NK细胞的制备方法通过磁珠筛选以及特异性的诱导优化获得了高活性、高纯度的NK细胞，所述靶向CD38的单抗也具有较好的结合特性以及特异性。该组合物能够有效的抑制多发性骨髓瘤移植瘤的生成，具有极佳的应用价值。（The present invention provides a pharmaceutical composition containing NK cells and its use for treating cancer, wherein the composition comprises NK cells optimized by the inventor and a newly prepared antibody targeting CD38. The preparation method of the NK cells obtains NK cells with high activity and purity through magnetic bead screening and specific induction optimization. The CD38-targeted monoclonal antibody also has good binding characteristics and specificity. The composition can effectively inhibit the formation of multiple myeloma transplantation tumors, and has excellent application value.）
近年来，恩大细胞基因着重加大对科研的投入力度，积极开展技术创新工作，通过多年的努力，公司有了大量的专利储存量，到目前恩大细胞基因先后获得专利证书7项；相关著作权登记证书21项，这些专利成果为公司开拓市场，提高公司的核心竞争力，提供了强有力的科技支撑。在未来的发展中，恩大细胞基因将更加注重自主创新能力的发展，把持续创新能力作为企业发展的固化机制，为企业持续、健康、快速发展提供强有力的支撑，力争成为引领行业发展的新标杆！（In recent years, NDA Cell Gene has focused on increasing its investment in scientific research and actively carried out technological innovation. Through years of hard work, the company has a certain amount of patent storage. Up to now, NDA Cell Gene has obtained 6 patent certificates; software; There are 21 copyright registration certificates. These patent achievements have provided strong scientific and technological support for the company to open up the market and improve the company's core competitiveness. In the future development, Enda Cell Genes will pay more attention to the development of independent innovation capabilities, and regard continuous innovation capabilities as a solidification mechanism for corporate development, providing strong support for the continuous, healthy and rapid development of the company, and strive to become a leader in the development of the industry. New benchmark!）
